【讨论】 膀胱癌（carcinoma of urinary bladder）多为移行细胞癌（占92%），少数为鳞状细胞癌和腺癌。40岁以上多见，高发年龄段50～60岁，好发于成年男性，男女比例约4：1。
基于92个网页-相关网页
Renal cell carcinoma (RCC) is one of the malignant tumors which is secondary to carcinoma of urinary bladder in the urinary carcinoma.
肾癌发病率在泌尿系肿瘤中仅次于膀胱癌位于第二位。
参考来源 - 早期肾癌保肾手术安全范围的研究·2,447,543篇论文数据，部分数据来源于NoteExpress
In the cases of upper urinary tract carcinoma associated with bladder carcinoma, higher grade malignancy and lower ureter carcinoma the recurrence rate was higher and usually occurred within 3 years.
上尿路移行细胞癌合并膀胱癌、肿瘤恶性程度高及输尿管下段癌其术后膀胱癌的再发率高，再发时间多在术后3年以内。
Bladder cancer is the most popular malignant tumor in urinary system and transitional cell carcinoma (TCC) is the most common pathological type of it.
膀胱癌是泌尿系统最常见的恶性肿瘤之一，移行细胞癌(TCC)是其最常见病理类型。
Objective:To evaluate the use of urinary nuclear matrix protein 22 (NMP22)in the detection of postoperative recurrence of transitional cell carcinoma of the bladder.
目的：探讨尿核基质蛋白22 （NMP22）检测在膀胱癌术后复发监测中的应用价值。
应用推荐